您当前的位置：
首页 >
文章列表页 >
Active surveillance of drug safety and influential factors in pediatric patients with Mycoplasma pneumoniae pneumonia
更新时间：2025-11-25

    • Active surveillance of drug safety and influential factors in pediatric patients with Mycoplasma pneumoniae pneumonia

    • “A study conducted by Xinxiang Central Hospital shows that the incidence of adverse drug reactions in children with Mycoplasma pneumoniae pneumonia is relatively high. Allergic history, medication use quantity, and intravenous hormone use are independent risk factors, while azithromycin use is a protective factor.”
    • ZHONGGUO YAOFANG   Vol. 36, Issue 22, Pages: 2838-2844(2025)

    • DOI：10.6039/j.issn.1001-0408.2025.22.15    

      CLC： R978.1;R969.3

    • Received：16 May 2025，

      Revised：2025-10-21，

      Accepted：23 October 2025，

      Published：30 November 2025

    移动端阅览

  • WANG Yuefeng,GAO Qiang,QIN Ke.Active surveillance of drug safety and influential factors in pediatric patients with Mycoplasma pneumoniae pneumonia[J].ZHONGGUO YAOFANG,2025,36(22):2838-2844. DOI： 10.6039/j.issn.1001-0408.2025.22.15.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Evolutionary game and simulation analysis of add-on payment policy under DRG payment reform in China
Clinical observation of intravitreal injection of ranibizumab in the treatment of macular edema with different OCT subtypes of retinal vein obstruction
Analysis of clinical characteristics and influential factors of drug-induced liver injury in children caused by intravenous azithromycin
Clinical efficacy and influencing factors of ceftazidime and avibactam monotherapy versus combination therapy in the treatment of CRGNB infection
Study on the influential factors for clinical efficacy of polymyxin B combined with other antibiotics in the treatment of carbapenem-resistant Acinetobacter baumannii pulmonary infection

Related Author

CHEN Ye
LI Jiaming
YANG Fenghong
LI Wei
CHEN Ying
XUE Chao
CHEN Jiaxing
LI Wanhui

Related Institution

Market Access Policy Research Center， China Pharmaceutical University
School of International Pharmaceutical Business， China Pharmaceutical University
Dept. of Ophthalmology， Xinjiang Production and Construction Corps Hospital
Dept. of Ocular Trauma， Tianjin Eye Hospital
Dept. of Pharmacy， Hengshui People’s Hospital
0